Model: | Ratio |
Symbol | Title | Sector | Industry | M.Cap.[M] | Div Yield | Last Close | AvgVol 200d |
NVO | Novo Nordisk A/S | Healthcare | Drug Manufacturers - General | 306298 | 0.0233 | 67.55 | 6927012 |
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 737662 | 0.0073 | 776.72 | 3673197 |
Entry Threshold: | 2.00 | Exit Threshold: | 0.00 | ||
Max Duration: | 30 | Entry Mode: | Uptick | Reversals: | |
MA Period: | 15 | MA Type: | EMA | StdDev Period: | 15 |
RSI Period: | 14 | RSI Threshold: | 0 | ||
Margin Req. 1: | 100.0 | Margin Req. 2: | 100.0 | ||
Version: | 5 | Model Version: | 2016.1 | Bid-Ask 0.01 / 0.01 |
Initial Capital: | 10000.00 | Final Equity: | 15233.48 |
Total net P/L: | 5233.48 | Total ROI: | 52.33 % |
CAGR: | 8.50 % | Max. DD: | 15.56 % |
System Score: | 4.111 | Sharpe Ratio: | 1.749 |
Start Date: | 2020-01-02 | End Date: | 2025-02-28 |
Total days: | 1884 | ||
Commissions: | 296.00 | Comm.% P/L | 5.35 % |
Total Transactions: | 296 | Log. Linearity: | 78.504 % |
Total | ![]() |
![]() |
NVO | LLY | |
---|---|---|---|---|---|
Total Profit/Loss | 5529.48 | 936.53 | 4592.95 | 5930.46 | -400.98 |
Total Profit | 11643.94 | 4792.04 | 6851.90 | 13604.56 | 10172.42 |
Total Loss | 6114.46 | 3855.51 | 2258.95 | 7674.10 | 10573.40 |
Profit Factor | 1.90 | 1.24 | 3.03 | 1.77 | 0.96 |
Trades | 74 | 37 | 37 | 74 | 74 |
Winning Trades | 50 | 20 | 30 | 46 | 36 |
Losing Trades | 24 | 17 | 7 | 28 | 38 |
% Profitable | 67.00 | 54.00 | 81.00 | 62.00 | 48.00 |
Profit/Loss Per Trade % | 0.60 | 0.24 | 0.97 | 0.60 | -0.05 |
Profit Per Trade % | 1.82 | 1.89 | 1.77 | 2.28 | 2.19 |
Loss Per Trade % | 1.85 | 1.65 | 2.35 | 2.06 | 2.10 |
Days In Trade | 994 | 576 | 418 | 994 | 994 |
Days In Trade (Avg. Per Trade) | 13.43 | 15.57 | 11.30 | 13.43 | 13.43 |
% Days In Trade | 52.76 | 30.57 | 22.19 | 52.76 | 52.76 |